The iOS 18.5 beta has now moved to phase 2 as Apple looks to put the finishing touches before the public release is available for all iPhone users. We have already given you details on the iOS 18.5 ...

Sweden: A recent study published in Diabetes, Obesity and Metabolism has identified a potential biological marker tied to ...

Beta-blockers have become a commonly used and popular treatment for anxiety and panic, but research on their safety and ...

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, ...

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") , a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, ...

Copenhagen, Denmark Saturday, April 26, 2025, 18:00 Hrs [IST] ...

Fintel reports that on April 28, 2025, Cantor Fitzgerald initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Overweight recommendation. Analyst Price Forecast Suggests 266.21% Upside As ...

New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...

In in vitro and in vivo preclinical studies, ficerafusp alfa + a KRAS-G12C inhibitor (G12Ci) was shown to be more effective than G12Ci alone, with G12Ci-resistant lung cancer cells remaining ...